Article info
PDFOriginal Article
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer
- Correspondence to Gordon C Jayson, Manchester Cancer Research Centre, University of Manchester, Manchester M20 4GJ, UK; Gordon.Jayson{at}christie.nhs.uk
Citation
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer
Publication history
- Received September 12, 2018
- Revision received October 29, 2018
- Accepted November 2, 2018
- First published January 23, 2019.
Article Versions
- View the most recent version of this article
- You are currently viewing a Previous version of this article (31 March 2021).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.